Trial intelligence / Profile preview

Epinephrine vs Albuterol in Bronchiolitis

NCT00114478Phase 4Unknown

Sponsor
Kern Medical Center
Start
Nov 2003
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in bronchiolitis comparing Epinephrine with Albuterol (2 arms). Primary endpoint: Hospital Admission Rate at 72 hours. Status: unknown.

02

Drugs

epinephrinesalbutamol
03

Conditions

bronchiolitis

Beyond the preview

Go deeper on NCT00114478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00114478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call